Combination therapy of cisplatin and resveratrol to induce cellular aging in gastric cancer cells: Focusing on oxidative stress, and cell cycle arrest

Background: As a medical dilemma, gastric cancer will have 7.3 million new cases in 2040. Despite the disease’s high economic and global burden, conventional chemotherapy regimens containing cisplatin have insufficient effectiveness and act non-specifically, leading to several adverse drug reactions...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahimifard, Mahban, Baeeri, Maryam, Mousavi, Taraneh, Azarnezhad, Asaad, Haghi-Aminjan, Hamed, Abdollahi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846154/
https://www.ncbi.nlm.nih.gov/pubmed/36686661
http://dx.doi.org/10.3389/fphar.2022.1068863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846154/
https://www.ncbi.nlm.nih.gov/pubmed/36686661
http://dx.doi.org/10.3389/fphar.2022.1068863

Ejemplares similares